611

N-[(E)-3-[(2R,3S,4R,5S)-3,4-dihydroxy-5-pyridin-4-ylsulfanyl-oxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide

Created:	2010-08-24
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where 611 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	4
Bond Count	52
Aromatic Bond Count	12

2D diagram of 611

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(E)-3-[(2R,3S,4R,5S)-3,4-dihydroxy-5-pyridin-4-ylsulfanyl-oxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide
Systematic Name (OpenEye OEToolkits)	N-[(E)-3-[(2R,3S,4R,5S)-3,4-dihydroxy-5-pyridin-4-ylsulfanyl-oxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide
Formula	C₁₉ H₁₉ N₃ O₈ S
Molecular Weight	449.434
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	[O-][N+](=O)c1cc(c(O)c(O)c1)C(=O)NC/C=C/C3OC(Sc2ccncc2)C(O)C3O
SMILES	CACTVS	3.370	O[CH]1[CH](O)[CH](O[CH]1Sc2ccncc2)C=CCNC(=O)c3cc(cc(O)c3O)[N+]([O-])=O
SMILES	OpenEye OEToolkits	1.7.0	c1cnccc1SC2C(C(C(O2)C=CCNC(=O)c3cc(cc(c3O)O)[N+](=O)[O-])O)O
Canonical SMILES	CACTVS	3.370	O[C@@H]1[C@H](O)[C@H](O[C@H]1Sc2ccncc2)\C=C\CNC(=O)c3cc(cc(O)c3O)[N+]([O-])=O
Canonical SMILES	OpenEye OEToolkits	1.7.0	c1cnccc1S[C@H]2[C@@H]([C@@H]([C@H](O2)/C=C/CNC(=O)c3cc(cc(c3O)O)[N+](=O)[O-])O)O
InChI	InChI	1.03	InChI=1S/C19H19N3O8S/c23-13-9-10(22(28)29)8-12(15(13)24)18(27)21-5-1-2-14-16(25)17(26)19(30-14)31-11-3-6-20-7-4-11/h1-4,6-9,14,16-17,19,23-26H,5H2,(H,21,27)/b2-1+/t14-,16-,17-,19+/m1/s1
InChIKey	InChI	1.03	XRZIENNFYKGKSZ-GXSCOFJOSA-N

Related Resource References

Resource Name	Reference
PubChem	50919271

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.